(Q44933274)

7 December 2017

title

CEL-1000--a peptide with adjuvant activity for Th1 immune responses (English)

1 reference

7 December 2017

Yupin Charoenvit

1

1 reference

7 December 2017

Neena Goel

2

1 reference

7 December 2017

Michael Whelan

3

1 reference

7 December 2017

Kenneth S Rosenthal

4

1 reference

7 December 2017

Daniel H Zimmerman

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

19

1 reference

7 December 2017

page(s)

2368-2373

1 reference

Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Immunization with a LEAPS heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Cytokine-containing liposomes as adjuvants for HIV subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Immunoadjuvant action of plasmid DNA in liposomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.062

10.1016/J.VACCINE.2003.11.062

7 January 2021

Identifiers

DOI

1 reference

release_34fzx4z7jnhhpfxyksrfyeqk7u

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/34fzx4z7jnhhpfxyksrfyeqk7u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference